2021 annual financial data
Immunocore Holdings 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -529.15%.
Operating income was -129,417,153 GBP and net income was -133,451,177 GBP.
Operating cash flow was -143,106,000 GBP.
Get free Immunocore Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 27,044,713 GBP
- Operating income
- -129,417,153 GBP
- Net income
- -133,451,177 GBP
- Operating cash flow
- -143,106,000 GBP